Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hitomi Seki"'
Autor:
Haruka Nishihara, Mai Watanabe, Ryosuke Kawakami, Masamoto Murakami, Hitomi Seki, Katsuki Osaki, Teruko Tsuda, Takeshi Imamura, Shingo Hadano, Shigeru Watanabe, Yosuke Niko
Publikováno v:
Bulletin of the Chemical Society of Japan; Mar2024, Vol. 97 Issue 3, p1-8, 8p
Autor:
Masuomi Kaneko, Taku Nakayama, Hitomi Seki, Shinkuro Yamamoto, Takumi Uemura, Keiji Inoue, Shingo Hadano, Shigeru Watanabe, Yosuke Niko
Publikováno v:
Bulletin of the Chemical Society of Japan. 95:1760-1768
Autor:
Andrey S. Klymchenko, Jurga Valanciunaite, Emilie Kempf, Nadine Peyriéras, Dmytro I. Danylchuk, Hitomi Seki, Yosuke Niko
Publikováno v:
Analytical Chemistry
Analytical Chemistry, American Chemical Society, 2020, 92 (9), pp.6512. ⟨10.1021/acs.analchem.0c00023⟩
Analytical Chemistry, American Chemical Society, 2020, 92 (9), pp.6512. ⟨10.1021/acs.analchem.0c00023⟩
International audience; Solvatochromic dyes enable sensing and imaging of biomolecular organization in living systems by monitoring local polarity (lipophilicity), but most such dyes suffer from limited brightness, photostability, lack of a convenien
Autor:
Taku Nakayama, Takashi Karashima, Chiaki Kawada, Shun-ichiro Ogura, Keiji Inoue, Hideo Fukuhara, Hitomi Seki, Shinkuro Yamamoto
Publikováno v:
Photodiagnosis and photodynamic therapy. 35
Background Photodynamic therapy (PDT) is a minimally invasive cancer therapy. However, its therapeutic efficacy for prostate cancer is not yet fully understood. In this study, the predictors of therapeutic efficacy of 5-aminolevulinic acid-based PDT
Autor:
Shingo Hadano, Naoya Asamura, Hitomi Seki, Shozo Onishi, Yasutaka Suzuki, Shigeru Watanabe, Yosuke Niko, Jun Kawamata, Daisuke Kaneno
Publikováno v:
Journal of Materials Chemistry B. 6:7396-7401
Since mitochondrial dysfunction was discovered to be the underlying cause of several severe diseases, fluorescent probes with excellent optical properties for visualising and monitoring the mitochondrial membrane potential (MMP) (a parameter of mitoc
Autor:
Shinkuro Yamamoto, Taku Nakayama, Takashi Karashima, Chiaki Kawada, Keiji Inoue, Shun-ichiro Ogura, Hideo Fukuhara, Hitomi Seki
Publikováno v:
Photodiagnosis and Photodynamic Therapy. 35:102427
Background Photodynamic therapy is a clinically approved, minimally invasive , therapeutic procedure used for the treatment of several cancers. In recent years, sunitinib, one of the tyrosine kinase inhibitors, has also attracted attention as a novel
Autor:
Noah A. Schenk, Chase Amos, Volker Kiessling, Alex J. B. Kreutzberger, Andrey S. Klymchenko, Weronika Tomaka, Yosuke Niko, Arun Anantharam, Hitomi Seki, Mounir Bendahmane, Lukas K. Tamm
Publikováno v:
Biophysical Journal. 118:401a-402a
Autor:
Miwa Nahata, Sachiko Mogami, Hitomi Sekine, Seiichi Iizuka, Naoto Okubo, Naoki Fujitsuka, Hiroshi Takeda
Publikováno v:
npj Aging and Mechanisms of Disease, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract Chronic undernutrition contributes to the increase in frailty observed among elderly adults, which is a pressing issue in the sector of health care for older people worldwide. Autophagy, an intracellular recycling system, is closely associat
Externí odkaz:
https://doaj.org/article/2976f3861c604a40a8c972724066b04e
Autor:
Taro Oshiro, Yumi Harada, Kunitsugu Kubota, Daichi Sadatomi, Hitomi Sekine, Mitsue Nishiyama, Naoki Fujitsuka
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 152, Iss , Pp 113263- (2022)
Changes in the intestinal microbiota are known to occur in constipated patients. Dietary fiber restriction presents obstacles to appropriate defecation and affects fecal properties, but the relationship between fecal microbiota and fecal morphologica
Externí odkaz:
https://doaj.org/article/aceae46b608c4adc9886e79375d236e7
Autor:
Chinami Matsumoto, Hitomi Sekine, Nana Zhang, Sachiko Mogami, Naoki Fujitsuka, Hiroshi Takeda
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9176 (2023)
Chemotherapy-induced sarcopenia is an unfavorable prognostic factor implicated in the development of postoperative complications and reduces the quality of life of patients with cancer. Skeletal muscle loss due to cisplatin use is caused by mitochond
Externí odkaz:
https://doaj.org/article/f95e49e47d144cc6bee8e74000c08430